- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.06. | Incannex receives U.S. patent for sleep apnea drug IHL-42X | 2 | Investing.com | ||
| 25.06. | Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | 447 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| 25.06. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.06. | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | 417 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare: Incannex Announces Initiation of Research Coverage by Alliance Global Partners | 267 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | Incannex Healthcare Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.05. | Incannex launches DReAMzz study for sleep apnea treatment | 2 | Investing.com | ||
| INCANNEX HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 14.05. | Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | 512 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for... ► Artikel lesen | |
| 12.05. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 22.04. | Incannex begrüßt US-Erlass zur Beschleunigung von Therapien für psychische Erkrankungen | 1 | Investing.com Deutsch | ||
| 22.04. | Incannex supports White House order on mental health treatments | 4 | Investing.com | ||
| 22.04. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 27.03. | Incannex reaktiviert Aktienrückkaufprogramm nach Phase der Inaktivität | 2 | Investing.com Deutsch | ||
| 27.03. | Incannex resumes share buyback after period of inactivity | 1 | Investing.com | ||
| 27.03. | Incannex Healthcare: Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position | 1 | GlobeNewswire (USA) | ||
| 25.03. | Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research | 2 | GlobeNewswire (USA) | ||
| 25.03. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.03. | Incannex reports $75M cash position with no debt after financing | 3 | Investing.com | ||
| 17.03. | Incannex erfüllt wieder NASDAQ-Mindestkursanforderung | - | Investing.com Deutsch |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,890 | +0,40 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| MCKESSON | 717,60 | +0,53 % | Ritchie John Torres purchases McKesson Corporation stock | ||
| HEALWELL AI | 0,463 | -0,64 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 7,920 | -0,38 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| SENSEONICS | 4,560 | -2,15 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| IMUNON | 1,650 | -4,62 % | Celsion Bank wird Mitglied des Liechtensteinischen Bankenverbandes | Vaduz - Die Celsion Bank AG ist seit 1. Juli 2026 Vollmitglied des Liechtensteinischen Bankenverbandes (LBV). Die Celsion Bank bringt ein klares Profil mit Fokus auf digitale Vermögenswerte ein und... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,510 | -7,72 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor | SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 45,200 | 0,00 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| INSPIREMD | 0,610 | -3,17 % | InspireMD Inc.: InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures | MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,385 | -0,75 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,990 | +1,02 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,700 | -0,87 % | Inogen appoints Andy Reding as chief operating officer | ||
| INTELLIGENT BIO SOLUTIONS | 2,290 | -0,43 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| GLUCOTRACK | 0,499 | +7,64 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,580 | -2,50 % | Lexaria Bioscience Corp. - 10-Q, Quarterly Report |
Das Unternehmen INCANNEX HEALTHCARE INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 3,310 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INCANNEX HEALTHCARE INC finden Sie auf Wallstreet Online.